Bon Scent Sparkling Tooth Wash

Description

The product is identified by the SPL code 34089-3. No specific description details are provided in the text.

Uses and Indications

This drug is indicated for the protection against cavities.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Healthcare professionals should instruct patients to place one tablet in their mouth. The patient should then use their tongue and lips to wash the gums, teeth, and tongue thoroughly. Following this, it is essential for the patient to rinse their mouth several times with water to ensure complete cleansing.

Contraindications

Use is contraindicated in children under 6 years of age. This precaution is necessary to prevent potential harm due to the product's formulation or effects in this age group. There are no additional contraindications, controlled substance classifications, or concerns regarding abuse, misuse, or dependence associated with this product.

Warnings and Precautions

It is essential to adhere to specific storage and safety guidelines to ensure the safe use of this product.

Storage Conditions The product must be stored in a cool and dry place to maintain its efficacy and safety.

Usage Precautions This product is not intended for ingestion; therefore, it should not be swallowed. The fluorine content is measured at 583.21 ppm, which is within the acceptable limit of less than 1,000 ppm.

Pediatric Considerations In the event that a child under the age of 6 years accidentally swallows a large quantity of the product, it is imperative to consult a physician or dentist immediately. Additionally, the product should be kept out of the reach of children under 6 years to prevent accidental ingestion.

Side Effects

In clinical use, it is important to note that if a child under 6 years of age swallows large quantities of the product, immediate consultation with a physician or dentist is advised. Additionally, the product should be kept out of the reach of children under 6 years to prevent accidental ingestion and potential adverse effects.

These warnings highlight the necessity for caregivers to be vigilant regarding the storage and accessibility of the product to ensure the safety of young children.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified in the available data. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Bon Scent Sparkling Tooth Wash (sodium fluoride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 6 years of age should be closely monitored, as ingestion of large quantities may necessitate immediate consultation with a physician or dentist. It is crucial to keep this product out of the reach of children in this age group to prevent accidental ingestion and potential harm.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

There is no specific information regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. Women of childbearing potential should be counseled on the importance of effective contraception during treatment and the need to inform their healthcare provider if they become pregnant or plan to become pregnant while on this medication.

Lactation

There are no specific warnings or recommendations regarding the use of this medication in nursing mothers. Additionally, there are no specific warnings or recommendations related to lactation. Healthcare professionals should consider the absence of data when advising lactating mothers on the use of this medication.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In cases of overdosage, particularly in pediatric patients, immediate medical consultation is crucial. If a child under 6 years of age has ingested large quantities of the medication, it is imperative to seek advice from a physician or dentist without delay.

Healthcare professionals should be aware of the potential symptoms that may arise from overdosage, although specific symptoms are not detailed in the provided information. It is essential to monitor the patient closely for any adverse effects and to initiate appropriate management procedures based on clinical judgment and the specific circumstances of the case.

In all instances of suspected overdosage, prompt evaluation and intervention are recommended to mitigate potential risks and ensure patient safety.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of the reach of children under 6 years. It is important to emphasize the potential risks associated with accidental ingestion by young children and to encourage patients to store the medication in a secure location.

Storage and Handling

The product is supplied in a configuration that ensures optimal handling and storage. It is essential to store the product in a cool and dry place to maintain its integrity and effectiveness.

Special attention should be given to ensure that the product is kept out of the reach of children under 6 years of age. Additionally, it is important to note that the product should not be swallowed. Proper adherence to these storage and handling guidelines will help ensure safety and efficacy.

Additional Clinical Information

The medication is administered orally. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Bon Scent Sparkling Tooth Wash, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)